Trade KRYS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Krystal Biotech, Inc. (KRYS) is trading at US$351.51, down 1.66% today as of Aug 28, 10:27 EDT. The company has a market capitalisation of US$10.26B. Over the past 52 weeks, KRYS has traded between US$136.73 and US$382.54. On Syfe you can trade KRYS with $0 commission and add it to your watchlist.
| Previous close | US$357.46 |
|---|---|
| Market cap | US$10.26B |
| P/E ratio | 39.91 |
| 52-week range | US$136.73 – US$382.54 |
| Volume | 181.37K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Krystal Biotech, Inc.
Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Year: 2017
Krystal Biotech, Inc. (KRYS) stock is trading at US$351.51, -1.66% from the previous close of US$357.46.
The market cap for Krystal Biotech, Inc. (KRYS) stock is approximately US$10.26B.
The price-to-earnings ratio for Krystal Biotech, Inc. (KRYS) is 39.91, based on the latest reported earnings.
The 52-week high for Krystal Biotech, Inc. (KRYS) stock is US$382.54.
The 52-week low for Krystal Biotech, Inc. (KRYS) stock is US$136.73.
Krystal Biotech, Inc. (KRYS) does not currently pay a dividend.
Stay on top of KRYS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
